http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 09 Sep 2026 06:07:48 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/New+Coverage/UBS+Assumes+Qiagen+NV+%28QGEN%29+at+Neutral/27038775.html <p>UBS analyst Douglas Schenkel assumes coverage on Qiagen NV (NYSE: QGEN) with a Neutral rating and a price target of $47.00.</p> <p>For an analyst ratings summary and ratings history on Qiagen NV <a href="http://www.streetinsider.com/rating_history.php?q=QGEN">click here</a>. For more ratings news on Qiagen NV <a href="http://www.streetinsider.com/stock_lookup_news.php?q=QGEN&amp;type=analyst">click here</a>.</p> <p>Shares of Qiagen NV closed at $42.38 yesterday.</p> http://www.streetinsider.com/New+Coverage/UBS+Assumes+Qiagen+NV+%28QGEN%29+at+Neutral/27038775.html Wed, 09 Sep 2026 06:07:48 -0400 QGEN http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++QIAGEN+N.V.+++++++++++++++For%3A+Sep+30/27038621.html si-local-file:///var/storage/secattach/20260909/27038621.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++QIAGEN+N.V.+++++++++++++++For%3A+Sep+30/27038621.html Wed, 09 Sep 2026 06:02:00 -0400 QGEN http://www.streetinsider.com/Litigation/Jury+finds+Parse+Biosciences+willfully+infringed+10x+Genomics+patents/26996945.html <p>A federal jury in the U.S. District Court for the District of Delaware found that Parse Biosciences, a subsidiary of Qiagen (NYSE: QGEN), willfully infringed three patents exclusively licensed to Scale Biosciences, which was acquired by 10x Genomics (NASDAQ: TXG) in 2025. The jury also upheld the validity of all three patents, rejecting Parse's invalidity challenges.</p><p>The jury awarded 10x Genomics more than $4.8 million in damages covering sales of Parse's Evercode Whole Transcriptome products from February 2021 through June 30, 2026. The award is based on a 14% royalty rate applied to infringing Parse sales. The patents at issue are http://www.streetinsider.com/Litigation/Jury+finds+Parse+Biosciences+willfully+infringed+10x+Genomics+patents/26996945.html Fri, 28 Aug 2026 14:41:07 -0400 QGEN TXG http://www.streetinsider.com/Litigation/Jury+finds+Parse+Biosciences+willfully+infringed+10x+Genomics+patents/26996945.html <p>A federal jury in the U.S. District Court for the District of Delaware found that Parse Biosciences, a subsidiary of Qiagen (NYSE: QGEN), willfully infringed three patents exclusively licensed to Scale Biosciences, which was acquired by 10x Genomics (NASDAQ: TXG) in 2025. The jury also upheld the validity of all three patents, rejecting Parse's invalidity challenges.</p><p>The jury awarded 10x Genomics more than $4.8 million in damages covering sales of Parse's Evercode Whole Transcriptome products from February 2021 through June 30, 2026. The award is based on a 14% royalty rate applied to infringing Parse sales. The patents at issue are http://www.streetinsider.com/Litigation/Jury+finds+Parse+Biosciences+willfully+infringed+10x+Genomics+patents/26996945.html Fri, 28 Aug 2026 14:41:07 -0400 QGEN TXG http://www.streetinsider.com/Press+Releases/10x+Genomics+Wins+Patent+Infringement+Verdict+Against+Parse+Biosciences/26996925.html <div class="xn-content"> <p class="prntac"><i>Jury finds Parse willfully infringed <span value="ACORN:5021697474" idsrc="xmltag.org" >Scale Biosciences'</span> patents and rejects Parse's invalidity challenge</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.pleton" idsrc="xmltag.org" >PLEASANTON, Calif.</location></span>, <span class="legendSpanClass"><chron>Aug. 28, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:TXG" idsrc="xmltag.org" >10x Genomics, Inc.</span> (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today announced that a jury in the <span>U.S. District Court for the District of Delaware</span> found that <span value="ACORN:5021695405" idsrc="xmltag.org" >Parse Biosciences</span>, now a subsidiary of Qiagen (NYSE: QGEN), willfully infringed three patents exclusively licensed to <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4762011-1&amp;h=159650850&amp;u=https%3A%2F%2Finvestors.10xgenomics.com%2Fnews%2Fnews-details%2F2025%2F10x-Genomics-to-Acquire-Scale-Biosciences%2Fdefault.aspx&amp;a=Scale+Biosciences%2C+part+of+10x+Genomics+since+2025" target="_blank" rel="nofollow"><span value="ACORN:5021697474" idsrc="xmltag.org" >Scale Biosciences</span>, part of <span value="NASDAQ-NMS:TXG" idsrc="xmltag.org" http://www.streetinsider.com/Press+Releases/10x+Genomics+Wins+Patent+Infringement+Verdict+Against+Parse+Biosciences/26996925.html Fri, 28 Aug 2026 14:38:00 -0400 A.17265613 A.50216954 A.50216974 O.00543542 O.50203413 O.53486142 O.57767466 O.60258322 QGEN TXG http://www.streetinsider.com/Press+Releases/10x+Genomics+Wins+Patent+Infringement+Verdict+Against+Parse+Biosciences/26996925.html <div class="xn-content"> <p class="prntac"><i>Jury finds Parse willfully infringed <span value="ACORN:5021697474" idsrc="xmltag.org" >Scale Biosciences'</span> patents and rejects Parse's invalidity challenge</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.pleton" idsrc="xmltag.org" >PLEASANTON, Calif.</location></span>, <span class="legendSpanClass"><chron>Aug. 28, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:TXG" idsrc="xmltag.org" >10x Genomics, Inc.</span> (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today announced that a jury in the <span>U.S. District Court for the District of Delaware</span> found that <span value="ACORN:5021695405" idsrc="xmltag.org" >Parse Biosciences</span>, now a subsidiary of Qiagen (NYSE: QGEN), willfully infringed three patents exclusively licensed to <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4762011-1&amp;h=159650850&amp;u=https%3A%2F%2Finvestors.10xgenomics.com%2Fnews%2Fnews-details%2F2025%2F10x-Genomics-to-Acquire-Scale-Biosciences%2Fdefault.aspx&amp;a=Scale+Biosciences%2C+part+of+10x+Genomics+since+2025" target="_blank" rel="nofollow"><span value="ACORN:5021697474" idsrc="xmltag.org" >Scale Biosciences</span>, part of <span value="NASDAQ-NMS:TXG" idsrc="xmltag.org" http://www.streetinsider.com/Press+Releases/10x+Genomics+Wins+Patent+Infringement+Verdict+Against+Parse+Biosciences/26996925.html Fri, 28 Aug 2026 14:38:00 -0400 A.17265613 A.50216954 A.50216974 O.00543542 O.50203413 O.53486142 O.57767466 O.60258322 QGEN TXG http://www.streetinsider.com/Press+Releases/10x+Genomics+Wins+Patent+Infringement+Verdict+Against+Parse+Biosciences/26996925.html <div class="xn-content"> <p class="prntac"><i>Jury finds Parse willfully infringed <span value="ACORN:5021697474" idsrc="xmltag.org" >Scale Biosciences'</span> patents and rejects Parse's invalidity challenge</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.pleton" idsrc="xmltag.org" >PLEASANTON, Calif.</location></span>, <span class="legendSpanClass"><chron>Aug. 28, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:TXG" idsrc="xmltag.org" >10x Genomics, Inc.</span> (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today announced that a jury in the <span>U.S. District Court for the District of Delaware</span> found that <span value="ACORN:5021695405" idsrc="xmltag.org" >Parse Biosciences</span>, now a subsidiary of Qiagen (NYSE: QGEN), willfully infringed three patents exclusively licensed to <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4762011-1&amp;h=159650850&amp;u=https%3A%2F%2Finvestors.10xgenomics.com%2Fnews%2Fnews-details%2F2025%2F10x-Genomics-to-Acquire-Scale-Biosciences%2Fdefault.aspx&amp;a=Scale+Biosciences%2C+part+of+10x+Genomics+since+2025" target="_blank" rel="nofollow"><span value="ACORN:5021697474" idsrc="xmltag.org" >Scale Biosciences</span>, part of <span value="NASDAQ-NMS:TXG" idsrc="xmltag.org" http://www.streetinsider.com/Press+Releases/10x+Genomics+Wins+Patent+Infringement+Verdict+Against+Parse+Biosciences/26996925.html Fri, 28 Aug 2026 14:38:00 -0400 A.17265613 A.50216954 A.50216974 O.00543542 O.50203413 O.53486142 O.57767466 O.60258322 QGEN TXG http://www.streetinsider.com/Press+Releases/10x+Genomics+Wins+Patent+Infringement+Verdict+Against+Parse+Biosciences/26996925.html <div class="xn-content"> <p class="prntac"><i>Jury finds Parse willfully infringed <span value="ACORN:5021697474" idsrc="xmltag.org" >Scale Biosciences'</span> patents and rejects Parse's invalidity challenge</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.pleton" idsrc="xmltag.org" >PLEASANTON, Calif.</location></span>, <span class="legendSpanClass"><chron>Aug. 28, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:TXG" idsrc="xmltag.org" >10x Genomics, Inc.</span> (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today announced that a jury in the <span>U.S. District Court for the District of Delaware</span> found that <span value="ACORN:5021695405" idsrc="xmltag.org" >Parse Biosciences</span>, now a subsidiary of Qiagen (NYSE: QGEN), willfully infringed three patents exclusively licensed to <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4762011-1&amp;h=159650850&amp;u=https%3A%2F%2Finvestors.10xgenomics.com%2Fnews%2Fnews-details%2F2025%2F10x-Genomics-to-Acquire-Scale-Biosciences%2Fdefault.aspx&amp;a=Scale+Biosciences%2C+part+of+10x+Genomics+since+2025" target="_blank" rel="nofollow"><span value="ACORN:5021697474" idsrc="xmltag.org" >Scale Biosciences</span>, part of <span value="NASDAQ-NMS:TXG" idsrc="xmltag.org" http://www.streetinsider.com/Press+Releases/10x+Genomics+Wins+Patent+Infringement+Verdict+Against+Parse+Biosciences/26996925.html Fri, 28 Aug 2026 14:38:00 -0400 A.17265613 A.50216954 A.50216974 O.00543542 O.50203413 O.53486142 O.57767466 O.60258322 QGEN TXG http://www.streetinsider.com/Press+Releases/10x+Genomics+Wins+Patent+Infringement+Verdict+Against+Parse+Biosciences/26996925.html <div class="xn-content"> <p class="prntac"><i>Jury finds Parse willfully infringed <span value="ACORN:5021697474" idsrc="xmltag.org" >Scale Biosciences'</span> patents and rejects Parse's invalidity challenge</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.pleton" idsrc="xmltag.org" >PLEASANTON, Calif.</location></span>, <span class="legendSpanClass"><chron>Aug. 28, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:TXG" idsrc="xmltag.org" >10x Genomics, Inc.</span> (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today announced that a jury in the <span>U.S. District Court for the District of Delaware</span> found that <span value="ACORN:5021695405" idsrc="xmltag.org" >Parse Biosciences</span>, now a subsidiary of Qiagen (NYSE: QGEN), willfully infringed three patents exclusively licensed to <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4762011-1&amp;h=159650850&amp;u=https%3A%2F%2Finvestors.10xgenomics.com%2Fnews%2Fnews-details%2F2025%2F10x-Genomics-to-Acquire-Scale-Biosciences%2Fdefault.aspx&amp;a=Scale+Biosciences%2C+part+of+10x+Genomics+since+2025" target="_blank" rel="nofollow"><span value="ACORN:5021697474" idsrc="xmltag.org" >Scale Biosciences</span>, part of <span value="NASDAQ-NMS:TXG" idsrc="xmltag.org" http://www.streetinsider.com/Press+Releases/10x+Genomics+Wins+Patent+Infringement+Verdict+Against+Parse+Biosciences/26996925.html Fri, 28 Aug 2026 14:38:00 -0400 A.17265613 A.50216954 A.50216974 O.00543542 O.50203413 O.53486142 O.57767466 O.60258322 QGEN TXG http://www.streetinsider.com/Press+Releases/10x+Genomics+Wins+Patent+Infringement+Verdict+Against+Parse+Biosciences/26996925.html <div class="xn-content"> <p class="prntac"><i>Jury finds Parse willfully infringed <span value="ACORN:5021697474" idsrc="xmltag.org" >Scale Biosciences'</span> patents and rejects Parse's invalidity challenge</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.pleton" idsrc="xmltag.org" >PLEASANTON, Calif.</location></span>, <span class="legendSpanClass"><chron>Aug. 28, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:TXG" idsrc="xmltag.org" >10x Genomics, Inc.</span> (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today announced that a jury in the <span>U.S. District Court for the District of Delaware</span> found that <span value="ACORN:5021695405" idsrc="xmltag.org" >Parse Biosciences</span>, now a subsidiary of Qiagen (NYSE: QGEN), willfully infringed three patents exclusively licensed to <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4762011-1&amp;h=159650850&amp;u=https%3A%2F%2Finvestors.10xgenomics.com%2Fnews%2Fnews-details%2F2025%2F10x-Genomics-to-Acquire-Scale-Biosciences%2Fdefault.aspx&amp;a=Scale+Biosciences%2C+part+of+10x+Genomics+since+2025" target="_blank" rel="nofollow"><span value="ACORN:5021697474" idsrc="xmltag.org" >Scale Biosciences</span>, part of <span value="NASDAQ-NMS:TXG" idsrc="xmltag.org" http://www.streetinsider.com/Press+Releases/10x+Genomics+Wins+Patent+Infringement+Verdict+Against+Parse+Biosciences/26996925.html Fri, 28 Aug 2026 14:38:00 -0400 A.17265613 A.50216954 A.50216974 O.00543542 O.50203413 O.53486142 O.57767466 O.60258322 QGEN TXG http://www.streetinsider.com/Press+Releases/10x+Genomics+Wins+Patent+Infringement+Verdict+Against+Parse+Biosciences/26996925.html <div class="xn-content"> <p class="prntac"><i>Jury finds Parse willfully infringed <span value="ACORN:5021697474" idsrc="xmltag.org" >Scale Biosciences'</span> patents and rejects Parse's invalidity challenge</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.pleton" idsrc="xmltag.org" >PLEASANTON, Calif.</location></span>, <span class="legendSpanClass"><chron>Aug. 28, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:TXG" idsrc="xmltag.org" >10x Genomics, Inc.</span> (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today announced that a jury in the <span>U.S. District Court for the District of Delaware</span> found that <span value="ACORN:5021695405" idsrc="xmltag.org" >Parse Biosciences</span>, now a subsidiary of Qiagen (NYSE: QGEN), willfully infringed three patents exclusively licensed to <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4762011-1&amp;h=159650850&amp;u=https%3A%2F%2Finvestors.10xgenomics.com%2Fnews%2Fnews-details%2F2025%2F10x-Genomics-to-Acquire-Scale-Biosciences%2Fdefault.aspx&amp;a=Scale+Biosciences%2C+part+of+10x+Genomics+since+2025" target="_blank" rel="nofollow"><span value="ACORN:5021697474" idsrc="xmltag.org" >Scale Biosciences</span>, part of <span value="NASDAQ-NMS:TXG" idsrc="xmltag.org" http://www.streetinsider.com/Press+Releases/10x+Genomics+Wins+Patent+Infringement+Verdict+Against+Parse+Biosciences/26996925.html Fri, 28 Aug 2026 14:38:00 -0400 A.17265613 A.50216954 A.50216974 O.00543542 O.50203413 O.53486142 O.57767466 O.60258322 QGEN TXG http://www.streetinsider.com/Press+Releases/10x+Genomics+Wins+Patent+Infringement+Verdict+Against+Parse+Biosciences/26996925.html <div class="xn-content"> <p class="prntac"><i>Jury finds Parse willfully infringed <span value="ACORN:5021697474" idsrc="xmltag.org" >Scale Biosciences'</span> patents and rejects Parse's invalidity challenge</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.pleton" idsrc="xmltag.org" >PLEASANTON, Calif.</location></span>, <span class="legendSpanClass"><chron>Aug. 28, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:TXG" idsrc="xmltag.org" >10x Genomics, Inc.</span> (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today announced that a jury in the <span>U.S. District Court for the District of Delaware</span> found that <span value="ACORN:5021695405" idsrc="xmltag.org" >Parse Biosciences</span>, now a subsidiary of Qiagen (NYSE: QGEN), willfully infringed three patents exclusively licensed to <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4762011-1&amp;h=159650850&amp;u=https%3A%2F%2Finvestors.10xgenomics.com%2Fnews%2Fnews-details%2F2025%2F10x-Genomics-to-Acquire-Scale-Biosciences%2Fdefault.aspx&amp;a=Scale+Biosciences%2C+part+of+10x+Genomics+since+2025" target="_blank" rel="nofollow"><span value="ACORN:5021697474" idsrc="xmltag.org" >Scale Biosciences</span>, part of <span value="NASDAQ-NMS:TXG" idsrc="xmltag.org" http://www.streetinsider.com/Press+Releases/10x+Genomics+Wins+Patent+Infringement+Verdict+Against+Parse+Biosciences/26996925.html Fri, 28 Aug 2026 14:38:00 -0400 A.17265613 A.50216954 A.50216974 O.00543542 O.50203413 O.53486142 O.57767466 O.60258322 QGEN TXG http://www.streetinsider.com/Press+Releases/10x+Genomics+Wins+Patent+Infringement+Verdict+Against+Parse+Biosciences/26996925.html <div class="xn-content"> <p class="prntac"><i>Jury finds Parse willfully infringed <span value="ACORN:5021697474" idsrc="xmltag.org" >Scale Biosciences'</span> patents and rejects Parse's invalidity challenge</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.pleton" idsrc="xmltag.org" >PLEASANTON, Calif.</location></span>, <span class="legendSpanClass"><chron>Aug. 28, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:TXG" idsrc="xmltag.org" >10x Genomics, Inc.</span> (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today announced that a jury in the <span>U.S. District Court for the District of Delaware</span> found that <span value="ACORN:5021695405" idsrc="xmltag.org" >Parse Biosciences</span>, now a subsidiary of Qiagen (NYSE: QGEN), willfully infringed three patents exclusively licensed to <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4762011-1&amp;h=159650850&amp;u=https%3A%2F%2Finvestors.10xgenomics.com%2Fnews%2Fnews-details%2F2025%2F10x-Genomics-to-Acquire-Scale-Biosciences%2Fdefault.aspx&amp;a=Scale+Biosciences%2C+part+of+10x+Genomics+since+2025" target="_blank" rel="nofollow"><span value="ACORN:5021697474" idsrc="xmltag.org" >Scale Biosciences</span>, part of <span value="NASDAQ-NMS:TXG" idsrc="xmltag.org" http://www.streetinsider.com/Press+Releases/10x+Genomics+Wins+Patent+Infringement+Verdict+Against+Parse+Biosciences/26996925.html Fri, 28 Aug 2026 14:38:00 -0400 A.17265613 A.50216954 A.50216974 O.00543542 O.50203413 O.53486142 O.57767466 O.60258322 QGEN TXG http://www.streetinsider.com/Press+Releases/10x+Genomics+Wins+Patent+Infringement+Verdict+Against+Parse+Biosciences/26996925.html <div class="xn-content"> <p class="prntac"><i>Jury finds Parse willfully infringed <span value="ACORN:5021697474" idsrc="xmltag.org" >Scale Biosciences'</span> patents and rejects Parse's invalidity challenge</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.pleton" idsrc="xmltag.org" >PLEASANTON, Calif.</location></span>, <span class="legendSpanClass"><chron>Aug. 28, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:TXG" idsrc="xmltag.org" >10x Genomics, Inc.</span> (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today announced that a jury in the <span>U.S. District Court for the District of Delaware</span> found that <span value="ACORN:5021695405" idsrc="xmltag.org" >Parse Biosciences</span>, now a subsidiary of Qiagen (NYSE: QGEN), willfully infringed three patents exclusively licensed to <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4762011-1&amp;h=159650850&amp;u=https%3A%2F%2Finvestors.10xgenomics.com%2Fnews%2Fnews-details%2F2025%2F10x-Genomics-to-Acquire-Scale-Biosciences%2Fdefault.aspx&amp;a=Scale+Biosciences%2C+part+of+10x+Genomics+since+2025" target="_blank" rel="nofollow"><span value="ACORN:5021697474" idsrc="xmltag.org" >Scale Biosciences</span>, part of <span value="NASDAQ-NMS:TXG" idsrc="xmltag.org" http://www.streetinsider.com/Press+Releases/10x+Genomics+Wins+Patent+Infringement+Verdict+Against+Parse+Biosciences/26996925.html Fri, 28 Aug 2026 14:38:00 -0400 A.17265613 A.50216954 A.50216974 O.00543542 O.50203413 O.53486142 O.57767466 O.60258322 QGEN TXG http://www.streetinsider.com/PRNewswire/10x+Genomics+Wins+Patent+Infringement+Verdict+Against+Parse+Biosciences/26996925.html <div class="xn-content"> <p class="prntac"><i>Jury finds Parse willfully infringed <span value="ACORN:5021697474" idsrc="xmltag.org" >Scale Biosciences'</span> patents and rejects Parse's invalidity challenge</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.pleton" idsrc="xmltag.org" >PLEASANTON, Calif.</location></span>, <span class="legendSpanClass"><chron>Aug. 28, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:TXG" idsrc="xmltag.org" >10x Genomics, Inc.</span> (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today announced that a jury in the <span>U.S. District Court for the District of Delaware</span> found that <span value="ACORN:5021695405" idsrc="xmltag.org" >Parse Biosciences</span>, now a subsidiary of Qiagen (NYSE: QGEN), willfully infringed three patents exclusively licensed to <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4762011-1&amp;h=159650850&amp;u=https%3A%2F%2Finvestors.10xgenomics.com%2Fnews%2Fnews-details%2F2025%2F10x-Genomics-to-Acquire-Scale-Biosciences%2Fdefault.aspx&amp;a=Scale+Biosciences%2C+part+of+10x+Genomics+since+2025" target="_blank" rel="nofollow"><span value="ACORN:5021697474" idsrc="xmltag.org" >Scale Biosciences</span>, part of <span value="NASDAQ-NMS:TXG" idsrc="xmltag.org" http://www.streetinsider.com/PRNewswire/10x+Genomics+Wins+Patent+Infringement+Verdict+Against+Parse+Biosciences/26996925.html Fri, 28 Aug 2026 14:38:00 -0400 A.17265613 A.50216954 A.50216974 O.00543542 O.50203413 O.53486142 O.57767466 O.60258322 QGEN TXG http://www.streetinsider.com/PRNewswire/10x+Genomics+Wins+Patent+Infringement+Verdict+Against+Parse+Biosciences/26996925.html <div class="xn-content"> <p class="prntac"><i>Jury finds Parse willfully infringed <span value="ACORN:5021697474" idsrc="xmltag.org" >Scale Biosciences'</span> patents and rejects Parse's invalidity challenge</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.pleton" idsrc="xmltag.org" >PLEASANTON, Calif.</location></span>, <span class="legendSpanClass"><chron>Aug. 28, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:TXG" idsrc="xmltag.org" >10x Genomics, Inc.</span> (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today announced that a jury in the <span>U.S. District Court for the District of Delaware</span> found that <span value="ACORN:5021695405" idsrc="xmltag.org" >Parse Biosciences</span>, now a subsidiary of Qiagen (NYSE: QGEN), willfully infringed three patents exclusively licensed to <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4762011-1&amp;h=159650850&amp;u=https%3A%2F%2Finvestors.10xgenomics.com%2Fnews%2Fnews-details%2F2025%2F10x-Genomics-to-Acquire-Scale-Biosciences%2Fdefault.aspx&amp;a=Scale+Biosciences%2C+part+of+10x+Genomics+since+2025" target="_blank" rel="nofollow"><span value="ACORN:5021697474" idsrc="xmltag.org" >Scale Biosciences</span>, part of <span value="NASDAQ-NMS:TXG" idsrc="xmltag.org" http://www.streetinsider.com/PRNewswire/10x+Genomics+Wins+Patent+Infringement+Verdict+Against+Parse+Biosciences/26996925.html Fri, 28 Aug 2026 14:38:00 -0400 A.17265613 A.50216954 A.50216974 O.00543542 O.50203413 O.53486142 O.57767466 O.60258322 QGEN TXG http://www.streetinsider.com/PRNewswire/10x+Genomics+Wins+Patent+Infringement+Verdict+Against+Parse+Biosciences/26996925.html <div class="xn-content"> <p class="prntac"><i>Jury finds Parse willfully infringed <span value="ACORN:5021697474" idsrc="xmltag.org" >Scale Biosciences'</span> patents and rejects Parse's invalidity challenge</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.pleton" idsrc="xmltag.org" >PLEASANTON, Calif.</location></span>, <span class="legendSpanClass"><chron>Aug. 28, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:TXG" idsrc="xmltag.org" >10x Genomics, Inc.</span> (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today announced that a jury in the <span>U.S. District Court for the District of Delaware</span> found that <span value="ACORN:5021695405" idsrc="xmltag.org" >Parse Biosciences</span>, now a subsidiary of Qiagen (NYSE: QGEN), willfully infringed three patents exclusively licensed to <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4762011-1&amp;h=159650850&amp;u=https%3A%2F%2Finvestors.10xgenomics.com%2Fnews%2Fnews-details%2F2025%2F10x-Genomics-to-Acquire-Scale-Biosciences%2Fdefault.aspx&amp;a=Scale+Biosciences%2C+part+of+10x+Genomics+since+2025" target="_blank" rel="nofollow"><span value="ACORN:5021697474" idsrc="xmltag.org" >Scale Biosciences</span>, part of <span value="NASDAQ-NMS:TXG" idsrc="xmltag.org" http://www.streetinsider.com/PRNewswire/10x+Genomics+Wins+Patent+Infringement+Verdict+Against+Parse+Biosciences/26996925.html Fri, 28 Aug 2026 14:38:00 -0400 A.17265613 A.50216954 A.50216974 O.00543542 O.50203413 O.53486142 O.57767466 O.60258322 QGEN TXG http://www.streetinsider.com/PRNewswire/10x+Genomics+Wins+Patent+Infringement+Verdict+Against+Parse+Biosciences/26996925.html <div class="xn-content"> <p class="prntac"><i>Jury finds Parse willfully infringed <span value="ACORN:5021697474" idsrc="xmltag.org" >Scale Biosciences'</span> patents and rejects Parse's invalidity challenge</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.pleton" idsrc="xmltag.org" >PLEASANTON, Calif.</location></span>, <span class="legendSpanClass"><chron>Aug. 28, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:TXG" idsrc="xmltag.org" >10x Genomics, Inc.</span> (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today announced that a jury in the <span>U.S. District Court for the District of Delaware</span> found that <span value="ACORN:5021695405" idsrc="xmltag.org" >Parse Biosciences</span>, now a subsidiary of Qiagen (NYSE: QGEN), willfully infringed three patents exclusively licensed to <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4762011-1&amp;h=159650850&amp;u=https%3A%2F%2Finvestors.10xgenomics.com%2Fnews%2Fnews-details%2F2025%2F10x-Genomics-to-Acquire-Scale-Biosciences%2Fdefault.aspx&amp;a=Scale+Biosciences%2C+part+of+10x+Genomics+since+2025" target="_blank" rel="nofollow"><span value="ACORN:5021697474" idsrc="xmltag.org" >Scale Biosciences</span>, part of <span value="NASDAQ-NMS:TXG" idsrc="xmltag.org" http://www.streetinsider.com/PRNewswire/10x+Genomics+Wins+Patent+Infringement+Verdict+Against+Parse+Biosciences/26996925.html Fri, 28 Aug 2026 14:38:00 -0400 A.17265613 A.50216954 A.50216974 O.00543542 O.50203413 O.53486142 O.57767466 O.60258322 QGEN TXG http://www.streetinsider.com/PRNewswire/10x+Genomics+Wins+Patent+Infringement+Verdict+Against+Parse+Biosciences/26996925.html <div class="xn-content"> <p class="prntac"><i>Jury finds Parse willfully infringed <span value="ACORN:5021697474" idsrc="xmltag.org" >Scale Biosciences'</span> patents and rejects Parse's invalidity challenge</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.pleton" idsrc="xmltag.org" >PLEASANTON, Calif.</location></span>, <span class="legendSpanClass"><chron>Aug. 28, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:TXG" idsrc="xmltag.org" >10x Genomics, Inc.</span> (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today announced that a jury in the <span>U.S. District Court for the District of Delaware</span> found that <span value="ACORN:5021695405" idsrc="xmltag.org" >Parse Biosciences</span>, now a subsidiary of Qiagen (NYSE: QGEN), willfully infringed three patents exclusively licensed to <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4762011-1&amp;h=159650850&amp;u=https%3A%2F%2Finvestors.10xgenomics.com%2Fnews%2Fnews-details%2F2025%2F10x-Genomics-to-Acquire-Scale-Biosciences%2Fdefault.aspx&amp;a=Scale+Biosciences%2C+part+of+10x+Genomics+since+2025" target="_blank" rel="nofollow"><span value="ACORN:5021697474" idsrc="xmltag.org" >Scale Biosciences</span>, part of <span value="NASDAQ-NMS:TXG" idsrc="xmltag.org" http://www.streetinsider.com/PRNewswire/10x+Genomics+Wins+Patent+Infringement+Verdict+Against+Parse+Biosciences/26996925.html Fri, 28 Aug 2026 14:38:00 -0400 A.17265613 A.50216954 A.50216974 O.00543542 O.50203413 O.53486142 O.57767466 O.60258322 QGEN TXG http://www.streetinsider.com/PRNewswire/10x+Genomics+Wins+Patent+Infringement+Verdict+Against+Parse+Biosciences/26996925.html <div class="xn-content"> <p class="prntac"><i>Jury finds Parse willfully infringed <span value="ACORN:5021697474" idsrc="xmltag.org" >Scale Biosciences'</span> patents and rejects Parse's invalidity challenge</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.pleton" idsrc="xmltag.org" >PLEASANTON, Calif.</location></span>, <span class="legendSpanClass"><chron>Aug. 28, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:TXG" idsrc="xmltag.org" >10x Genomics, Inc.</span> (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today announced that a jury in the <span>U.S. District Court for the District of Delaware</span> found that <span value="ACORN:5021695405" idsrc="xmltag.org" >Parse Biosciences</span>, now a subsidiary of Qiagen (NYSE: QGEN), willfully infringed three patents exclusively licensed to <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4762011-1&amp;h=159650850&amp;u=https%3A%2F%2Finvestors.10xgenomics.com%2Fnews%2Fnews-details%2F2025%2F10x-Genomics-to-Acquire-Scale-Biosciences%2Fdefault.aspx&amp;a=Scale+Biosciences%2C+part+of+10x+Genomics+since+2025" target="_blank" rel="nofollow"><span value="ACORN:5021697474" idsrc="xmltag.org" >Scale Biosciences</span>, part of <span value="NASDAQ-NMS:TXG" idsrc="xmltag.org" http://www.streetinsider.com/PRNewswire/10x+Genomics+Wins+Patent+Infringement+Verdict+Against+Parse+Biosciences/26996925.html Fri, 28 Aug 2026 14:38:00 -0400 A.17265613 A.50216954 A.50216974 O.00543542 O.50203413 O.53486142 O.57767466 O.60258322 QGEN TXG http://www.streetinsider.com/PRNewswire/10x+Genomics+Wins+Patent+Infringement+Verdict+Against+Parse+Biosciences/26996925.html <div class="xn-content"> <p class="prntac"><i>Jury finds Parse willfully infringed <span value="ACORN:5021697474" idsrc="xmltag.org" >Scale Biosciences'</span> patents and rejects Parse's invalidity challenge</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.pleton" idsrc="xmltag.org" >PLEASANTON, Calif.</location></span>, <span class="legendSpanClass"><chron>Aug. 28, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:TXG" idsrc="xmltag.org" >10x Genomics, Inc.</span> (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today announced that a jury in the <span>U.S. District Court for the District of Delaware</span> found that <span value="ACORN:5021695405" idsrc="xmltag.org" >Parse Biosciences</span>, now a subsidiary of Qiagen (NYSE: QGEN), willfully infringed three patents exclusively licensed to <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4762011-1&amp;h=159650850&amp;u=https%3A%2F%2Finvestors.10xgenomics.com%2Fnews%2Fnews-details%2F2025%2F10x-Genomics-to-Acquire-Scale-Biosciences%2Fdefault.aspx&amp;a=Scale+Biosciences%2C+part+of+10x+Genomics+since+2025" target="_blank" rel="nofollow"><span value="ACORN:5021697474" idsrc="xmltag.org" >Scale Biosciences</span>, part of <span value="NASDAQ-NMS:TXG" idsrc="xmltag.org" http://www.streetinsider.com/PRNewswire/10x+Genomics+Wins+Patent+Infringement+Verdict+Against+Parse+Biosciences/26996925.html Fri, 28 Aug 2026 14:38:00 -0400 A.17265613 A.50216954 A.50216974 O.00543542 O.50203413 O.53486142 O.57767466 O.60258322 QGEN TXG http://www.streetinsider.com/PRNewswire/10x+Genomics+Wins+Patent+Infringement+Verdict+Against+Parse+Biosciences/26996925.html <div class="xn-content"> <p class="prntac"><i>Jury finds Parse willfully infringed <span value="ACORN:5021697474" idsrc="xmltag.org" >Scale Biosciences'</span> patents and rejects Parse's invalidity challenge</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.pleton" idsrc="xmltag.org" >PLEASANTON, Calif.</location></span>, <span class="legendSpanClass"><chron>Aug. 28, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:TXG" idsrc="xmltag.org" >10x Genomics, Inc.</span> (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today announced that a jury in the <span>U.S. District Court for the District of Delaware</span> found that <span value="ACORN:5021695405" idsrc="xmltag.org" >Parse Biosciences</span>, now a subsidiary of Qiagen (NYSE: QGEN), willfully infringed three patents exclusively licensed to <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4762011-1&amp;h=159650850&amp;u=https%3A%2F%2Finvestors.10xgenomics.com%2Fnews%2Fnews-details%2F2025%2F10x-Genomics-to-Acquire-Scale-Biosciences%2Fdefault.aspx&amp;a=Scale+Biosciences%2C+part+of+10x+Genomics+since+2025" target="_blank" rel="nofollow"><span value="ACORN:5021697474" idsrc="xmltag.org" >Scale Biosciences</span>, part of <span value="NASDAQ-NMS:TXG" idsrc="xmltag.org" http://www.streetinsider.com/PRNewswire/10x+Genomics+Wins+Patent+Infringement+Verdict+Against+Parse+Biosciences/26996925.html Fri, 28 Aug 2026 14:38:00 -0400 A.17265613 A.50216954 A.50216974 O.00543542 O.50203413 O.53486142 O.57767466 O.60258322 QGEN TXG http://www.streetinsider.com/PRNewswire/10x+Genomics+Wins+Patent+Infringement+Verdict+Against+Parse+Biosciences/26996925.html <div class="xn-content"> <p class="prntac"><i>Jury finds Parse willfully infringed <span value="ACORN:5021697474" idsrc="xmltag.org" >Scale Biosciences'</span> patents and rejects Parse's invalidity challenge</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.pleton" idsrc="xmltag.org" >PLEASANTON, Calif.</location></span>, <span class="legendSpanClass"><chron>Aug. 28, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:TXG" idsrc="xmltag.org" >10x Genomics, Inc.</span> (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today announced that a jury in the <span>U.S. District Court for the District of Delaware</span> found that <span value="ACORN:5021695405" idsrc="xmltag.org" >Parse Biosciences</span>, now a subsidiary of Qiagen (NYSE: QGEN), willfully infringed three patents exclusively licensed to <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4762011-1&amp;h=159650850&amp;u=https%3A%2F%2Finvestors.10xgenomics.com%2Fnews%2Fnews-details%2F2025%2F10x-Genomics-to-Acquire-Scale-Biosciences%2Fdefault.aspx&amp;a=Scale+Biosciences%2C+part+of+10x+Genomics+since+2025" target="_blank" rel="nofollow"><span value="ACORN:5021697474" idsrc="xmltag.org" >Scale Biosciences</span>, part of <span value="NASDAQ-NMS:TXG" idsrc="xmltag.org" http://www.streetinsider.com/PRNewswire/10x+Genomics+Wins+Patent+Infringement+Verdict+Against+Parse+Biosciences/26996925.html Fri, 28 Aug 2026 14:38:00 -0400 A.17265613 A.50216954 A.50216974 O.00543542 O.50203413 O.53486142 O.57767466 O.60258322 QGEN TXG http://www.streetinsider.com/PRNewswire/10x+Genomics+Wins+Patent+Infringement+Verdict+Against+Parse+Biosciences/26996925.html <div class="xn-content"> <p class="prntac"><i>Jury finds Parse willfully infringed <span value="ACORN:5021697474" idsrc="xmltag.org" >Scale Biosciences'</span> patents and rejects Parse's invalidity challenge</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.pleton" idsrc="xmltag.org" >PLEASANTON, Calif.</location></span>, <span class="legendSpanClass"><chron>Aug. 28, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:TXG" idsrc="xmltag.org" >10x Genomics, Inc.</span> (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today announced that a jury in the <span>U.S. District Court for the District of Delaware</span> found that <span value="ACORN:5021695405" idsrc="xmltag.org" >Parse Biosciences</span>, now a subsidiary of Qiagen (NYSE: QGEN), willfully infringed three patents exclusively licensed to <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4762011-1&amp;h=159650850&amp;u=https%3A%2F%2Finvestors.10xgenomics.com%2Fnews%2Fnews-details%2F2025%2F10x-Genomics-to-Acquire-Scale-Biosciences%2Fdefault.aspx&amp;a=Scale+Biosciences%2C+part+of+10x+Genomics+since+2025" target="_blank" rel="nofollow"><span value="ACORN:5021697474" idsrc="xmltag.org" >Scale Biosciences</span>, part of <span value="NASDAQ-NMS:TXG" idsrc="xmltag.org" http://www.streetinsider.com/PRNewswire/10x+Genomics+Wins+Patent+Infringement+Verdict+Against+Parse+Biosciences/26996925.html Fri, 28 Aug 2026 14:38:00 -0400 A.17265613 A.50216954 A.50216974 O.00543542 O.50203413 O.53486142 O.57767466 O.60258322 QGEN TXG http://www.streetinsider.com/Corporate+News/QIAGEN+launches+QIAsymphony+Connect+nucleic+acid+extraction+platform/26989996.html <p>QIAGEN N.V. (NYSE: QGEN) has commercially launched QIAsymphony Connect, an in vitro diagnostics (IVD)-compliant platform for automated clinical nucleic acid extraction, according to a company press release.</p><p>The platform is designed to standardize nucleic acid extraction across clinical molecular testing workflows, including liquid biopsy, oncology and infectious disease diagnostics. It can process up to 96 samples in four independent batches and supports sample input volumes ranging from a few microliters up to 10 mL.</p><p>QIAsymphony Connect is compatible with existing QIAsymphony reagent kits and consumables, which have been used across more than 3,300 cumulative placements of the previous QIAsymphony platform worldwide.</p><p>QIAGEN has http://www.streetinsider.com/Corporate+News/QIAGEN+launches+QIAsymphony+Connect+nucleic+acid+extraction+platform/26989996.html Thu, 27 Aug 2026 16:11:25 -0400 QGEN